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Abstract
Primary hyperparathyroidism (PHPT) is a common endocrine neoplastic disorder caused by a failure of calcium sensing secondary to tumour
development in one or more of the parathyroid glands. Parathyroid adenomas are comprised of distinct cellular subpopulations of variable clo-
nal status that exhibit differing degrees of calcium responsiveness. To gain a clearer understanding of the relationship among cellular identity,
tumour composition and clinical biochemistry in PHPT, we developed a novel single cell platform for quantitative evaluation of calcium sensing
behaviour in freshly resected human parathyroid tumour cells. Live-cell intracellular calcium flux was visualized through Fluo-4-AM epifluores-
cence, followed by in situ immunofluorescence detection of the calcium sensing receptor (CASR), a central component in the extracellular cal-
cium signalling pathway. The reactivity of individual parathyroid tumour cells to extracellular calcium stimulus was highly variable, with discrete
kinetic response patterns observed both between and among parathyroid tumour samples. CASR abundance was not an obligate determinant
of calcium responsiveness. Calcium EC50 values from a series of parathyroid adenomas revealed that the tumours segregated into two distinct
categories. One group manifested a mean EC50 of 2.40 mM (95% CI: 2.37–2.41), closely aligned to the established normal range. The second
group was less responsive to calcium stimulus, with a mean EC50 of 3.61 mM (95% CI: 3.45–3.95). This binary distribution indicates the exis-
tence of a previously unappreciated biochemical sub-classification of PHPT tumours, possibly reflecting distinct etiological mechanisms.
Recognition of quantitative differences in calcium sensing could have important implications for the clinical management of PHPT.
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Introduction
Primary hyperparathyroidism (PHPT) is a common endocrine neo-
plastic disorder, with an overall incidence of 15–30 per 100,000 indi-
viduals in the USA. [1–3]. The disease disproportionately affects the
elderly, with a prevalence rate of 99 affected individuals per 100,000
among women aged 65–74 years, a substantial clinical burden that is
projected to expand significantly as the nation’s median age rises
[4, 5]. The morbidity of PHPT can be significant, including bone loss
and fracture, nephrolithiasis, cardiovascular and gastrointestinal dis-
ease, and neurocognitive impairment [6]. These symptoms arise sec-
ondary to a metabolic disturbance in calcium homeostasis imparted
by dysregulated parathyroid hormone (PTH) secretion due to a failure
of calcium sensing in culprit adenomatous or hyperplastic parathyroid
glands [7]. Silencing or inactivation of the calcium sensing receptor
(CASR) coincident with the emergence of parathyroid neoplasia is the
presumptive primary mechanism for the loss of calcium sensing in
PHPT [8–11]. However, CASR genetic lesions are not found in spo-
radic PHPT [12–14], and multiple lines of evidence from our labora-
tory [15] and others [16–20] indicate that tumour aggregate CASR
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abundance is not predictive of relative calcium responsiveness. More-
over, we have recently shown that parathyroid adenomas are com-
prised of functionally distinct cellular subtypes that differ in their
relative sensitivity to calcium stimulation despite equivalent levels of
CASR expression in each population [21]. This evidence of intratu-
moural heterogeneity in the composition and biochemical behaviour
of parathyroid adenomas calls into question the assumption of CASR
down-regulation as an obligate mechanism in PHPT and highlights
the need for a means to interrogate intrinsic calcium responsiveness
of individual parathyroid tumour cells as a more direct functional
readout of the underlying calcium sensing deficit.
To investigate how intratumoural heterogeneity affects the cal-
cium sensing behaviour of parathyroid tumours, we sought to exam-
ine the dynamic response of parathyroid adenoma cells to
extracellular calcium challenge at single cell resolution. Here, we
describe a novel, optically transparent, indexed, micron scale live-cell
observation system that allows us to visualize and quantitate the cal-
cium responsiveness of individual cells isolated from surgically
resected human parathyroid adenomas. Using this device, a dynamic
profile of each cell’s intracellular signalling response following extra-
cellular calcium stimulus can be captured as a functional readout of
calcium sensing behaviour. The cells can subsequently be probed by
immunofluorescence in situ or recovered individually for downstream
molecular analysis. Utilizing the system’s capacity to align post-assay
immunofluorescence image analysis with the individual record of
each cell’s functional response, we show that the presence of detect-
able CASR protein is not the sole determinant of calcium sensitivity in
parathyroid adenoma cells. We report that ex vivo provocative testing
to evaluate the biochemical responsiveness of a series of parathyroid
adenoma cell isolates across a range of calcium doses reveals five
distinct kinetic patterns of calcium flux response. Distribution among
these categories at lower calcium concentrations is highly variable
between tumours but consolidates into either a maximal response or
non-response profile as calcium concentrations increased. When we
plotted the dose–response relationship between the proportion of
maximal responders and calcium concentration, we found that the
adenomas in our sample group appeared to segregate into two dis-
tinct categories with respect to calcium EC50. The emergence of
these biochemically defined subclasses of parathyroid tumours
suggests a previously unappreciated degree of functional heterogene-
ity in PHPT.
Materials and methods
Microfabrication
Microraft arrays were fabricated as previously reported [22]. Briefly, UV
photolithography was used to fabricate arrays of 50 9 50 9 40 lm
1002F photoresist pillars on a glass substrate. Soft lithography was
used to mold polydimethylsiloxane (PDMS) microwell arrays from the
templates. The PDMS microwell arrays were then dip-coated in a solu-
tion of poly(styrene-co-acrylic acid) doped with Fe2O3 nanoparticles in
c-butyrolactone, leaving a bead of the poly(styrene-co-acrylic acid) solu-
tion inside each PDMS microwell. After baking off the solvent, concave
microrafts remained within the microwells. The completed arrays were
attached to four-chambered computerized numerical control (CNC)-
milled polycarbonate cassettes by plasma-treating both surfaces and
then adhering them together using PDMS. In order to enhance surface
wettability, the microarrays attached to milled polycarbonate cassettes
were plasma-treated for 5 min., sterilized with ethanol, and coated with
glucose. Completed array dimensions are as follows: 26 9 26 mm
exterior; 50 9 50 lm2 rafts; 10 lm gaps between rafts. Each microraft
array contains approximately 180,000 rafts.
Cell culture
Parathyroid cell suspensions were prepared from surgically resected
adenoma tissue as previously described [21]. Briefly, the procedure was
as follows: the tissue specimens were rinsed in serum-free DMEM (cat.
no. 11995073; Life Technologies, Grand Island, NY, USA) supplemented
with an antibiotic/antimycotic solution (cat. no. A5955; Sigma-Aldrich,
St. Louis, MO, USA). In a laminar flow biosafety cabinet (Biosafety
Class II; Baker Company, Sanford, ME, USA), the tissue was minced
into 1–2 mm pieces using sterile instruments and then rinsed with
serum-free DMEM. The tissue fragments were transferred to a sterile
flask containing DMEM with 1 mg/ml collagenase (Type 1A, cat. no.
C2671; Sigma-Aldrich) and allowed to digest with constant stirring in a
humidified tissue culture incubator (Forma Model 3110; Thermo Scien-
tific, Marietta, OH, USA) set to 37°C and 5% CO2. Stirring occurred on
a sealed magnetic stirrer (cat. no. 0003671000; IKA Works, Wilmington,
NC, USA) placed inside the tissue culture incubator with the electrical
cord passing to an external outlet through a rear-facing port sealed with
a gas-tight silicone gasket. Collagenase digestion was allowed to pro-
ceed until >80% of the tissue was reduced to a mixture of single cells
and dispersed cell clumps (approximately 3–4 hrs on average). The cell
suspension was pelleted and resuspended in Liu primary cell media
[23] lacking the rho kinase inhibitor but containing 5% foetal bovine
serum to neutralize the collagenase. The primary cell media described
by Liu and co-workers incorporates the Rho kinase inhibitor Y-27632
(cat. no. ALX-270-333; Enzo Life Sciences, Farmingdale, NY, USA) at a
concentration of 5–10 micromolar to support long-term sustained cul-
ture of primary epithelial cells. We have found that the Y-27632 agent
is not required for parathyroid adenoma cell culture in our system and
thus we do not include it our media. The cells were filtered through a
50 lm mesh to remove fibrous tissue and were then plated at a density
of 5 9 104 cells/cm2. Calcium flux assays were initiated within 48 hrs
of the time of harvest, well before parathyroid cell viability in culture
begins to decline (typically at 7–14 days).
Calcium flux assay
Parathyroid cell cultures were harvested using Detachin (cat. no.
T100110; Genlantis, San Diego, CA, USA), and an aliquot was viewed
on a haemacytometer to estimate cell number and verify viability. The
cells were washed with low calcium (0.22 mM) Liu media, seeded into
the microraft grids and incubated overnight. The calcium flux imaging
assay was performed using the Fluo-4 NW calcium assay reagent
(cat. no. F36206; Life Technologies). The reagent was prepared
according to the manufacturer’s instructions. Cells in the microraft
wells were washed once with calcium-free buffer and were then incu-
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bated for 60 min. in Fluo-4-containing media to load the cells with
the indicator.
Microraft grids were placed in a live-cell epifluorescence imaging
system consisting of a Zeiss Axio Observer (Carl Zeiss AG, Oberkochen,
Germany) with a Hamamatsu Orca ER high resolution CCD camera and
a heated Z1 motorized stage within a humidified/5% CO2 enclosure.
After a brief baseline stabilization period, matched sets of identically
seeded grid chambers from each adenoma were challenged with a cal-
cium chloride stimulus across a range of final calcium concentrations
from 0.5 to 10 mM. Metamorph (v7.8) software (Molecular Devices,
Inc, Sunnyvale, CA, USA) in multichannel acquisition mode was used to
capture sequential fluorescence images every 5 sec. for 10 min., yield-
ing a time-lapse image stack of 121 sequential frames for each of three
separate fields per calcium concentration point. Flux measurements
were collected from a minimum of 200 cells at each calcium concentra-
tion point. A brightfield phase contrast image of each field was captured
at the beginning and at the end of the 10-min. observation period for
alignment. The exposure time for each fluorescence frame was set to
100 msec., with the brightfield channel exposure set to 50 msec.
Immunofluorescence
Immediately after completion of the flux assay measurements, the
media was removed, and the cells were washed twice with PBS. The
cells were then fixed in 3.7% paraformaldehyde (PFA) for 10 min., fol-
lowed by three washes in PBS. The fixed cells were permeabilized with
0.5% Triton X-100 in PBS for 15 min. and then washed again with
PBS. After blocking in 3% bovine serum albumin (BSA)/PBS for 1 hr at
room temperature, the cells were incubated with a mouse monoclonal
anti-CASR primary antibody (Clone 5C10, cat. no. NB120-19347; Novus,
Littleton, CO, USA) at a 1:1000 dilution. Isotype-matched mouse IgG at
the same concentration was used as a negative control. After washing,
CASR reactivity was visualized using an AlexaFluor488-conjugated goat
anti-mouse secondary antibody diluted 1:1000 in 3% BSA/PBS. The
secondary antibody incubation was followed by three washes, and then
the stained cells were overlaid with Prolong Gold antiquenching mount-
ing media containing DAPI as a nuclear counterstain. Background sub-
tracted anti-CASR immunfluorescence was quantitated as integrated
intensity (fluorescence intensity in the AlexaFluor488 emission wave-
length summed over all of the pixels within each cell boundary) for
each cell using the Metamorph region measurement tool.
Image analysis
Background subtraction was performed using the multichannel review
mode of Metamorph. Individual cells were marked manually as num-
bered regions using a standardized template. Fluorescence above back-
ground was calculated as integrated intensity for each cell region in
each of the 121 sequential images in each image stack using the Meta-
morph region measurement tool. Raw data including region area, aver-
age intensity, peak intensity, integrated intensity above background, well
location and related parameters were exported directly in Excel spread-
sheets. Fluorescence intensities were normalized to each cell’s zero
time-point value and kinetic response curves were plotted over the full
time course of each experiment. Kinetic profile categories are defined
as follows. The maximal response profile requires a sharp increase in
induced calcium flux within the first 60 sec. of Ca2+ exposure followed
by a sustained (<10% intensity deviation) plateau of fluorescence inten-
sity for the duration of the remaining observation period. The rapid/tran-
sient profile shows an immediate increase in fluorescence intensity
within 60 sec. of calcium stimulus with a return to baseline within the
subsequent 60-sec. time interval. Slow responders show a prolonged
interval of fluorescent intensity increase of >2 min. before achieving a
plateau phase. Multiple peak responders have at least two fluorescence
maxima separated by a return to baseline in the interpeak interval. Non-
responders show a <10% deviation from baseline over the entire obser-
vation period.
Procurement of patient material
Parathyroid cells were isolated from surgically resected adenoma tissue
obtained from patients with PHPT undergoing parathyroidectomy at
Duke University Medical Center. Tissue identity as parathyroid adenoma
was established by intraoperative PTH monitoring using the Miami crite-
ria [24] of a >50% decline from pre-operative PTH levels within
10 min. of tumour resection, and confirmed by post-operative
histopathological assessment of the surgical specimen. All procedures
on human subjects were reviewed and approved by the Duke University
Institutional Review Board (IRB). Patients pre-operatively diagnosed
with PHPT were recruited by endocrine surgery and enrolled in the
study after providing fully informed consent as described under an
active IRB-approved protocol. De-identified parathyroid adenoma surgi-
cal specimens were provided to the laboratory for immediate harvest
and recovery of live dispersed parathyroid cells as described above.
Results
The novel live-cell imaging approach we developed for quantitatively
interrogating the dynamic calcium responsiveness of human parathy-
roid tumour specimens at single cell resolution couples detection of
an intracellular calcium flux indicator (Fluo-4-AM) with a unique plat-
ing array device. In this system, parathyroid adenoma cells are
seeded in an optically transparent indexed grid array composed of a
large number of releasable lm-scale elements, termed microrafts,
doped with paramagnetic nanoparticles [25–27]. Four independent
grid chambers are held in a CNC-milled polycarbonate block that can
be mounted in a standard inverted microscope mechanized stage
(Fig. 1A). Each 50 9 50 lm2 microraft constitutes a discrete and
separable culture site with a unique address within the indexed grid
array (Fig. 1B). Dispersed parathyroid cell suspensions prepared
from surgically resected human parathyroid adenomas using previ-
ously established methods [21] adhered well to the microraft surface
(Fig. 1C) and maintained viability at >96% in culture (Fig. 1D).
The viability of the dispersed cell isolates was additionally docu-
mented by propidium iodide exclusion at the end of the calcium flux
assay to confirm the sustained integrity of the primary cells through
the duration of the experimental observation period (Table S1).
Expression of PTH, CASR, MEN1 and STAMBP was visualized by
immunofluorescence to confirm parathyroid identity (Fig. S1).
Parathyroid adenoma cells plated into microraft grid arrays were
interrogated functionally for responsiveness to extracellular calcium
challenge. An example of comparative single cell calcium flux
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response is shown in Figure 2, where a cluster of four cells in two
adjacent microrafts are found to display markedly different levels of
calcium response. The cells appear morphologically indistinguishable
under brightfield illumination (Fig. 2A), but upon stimulation with
2 mM CaCl2, two of the cells respond strongly while the remaining
two cells are non-responsive (Fig. 2B). A plot of integrated fluores-
cence intensity over time for these cells reveals the quantitatively dis-
tinct flux patterns manifested by the responsive (1 and 2) relative to
Fig. 1 Flexible micro-raft design. (A) Pho-
tograph of the microraft array platform
module with four independent grid cham-
bers. (B) Transmitted light microscopy
image of a microraft array with numeric
indices identifying the spatial location of
the field of view within the array; scale
bar: 200 lm. (C) Phase contrast image of
parathyroid cells adherently plated in a
microraft grid array. (D) Parathyroid cell
viability after plating. Viable cells are indi-
cated by Oregon green staining; non-
viable cells are marked by propidium
iodide staining (red).
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Fig. 2 Intracellular flux response of
parathyroid cells. (A) Phase contrast
image of parathyroid cells in two adjacent
micro-raft wells. (B) Sequential fluorescent
images of the same field of cells in (A)
after 2 mM calcium stimulus. White
numerals indicate number of seconds
after stimulus. Increasing fluorescence
intensity is indicated using a standard
pseudo-colour heat map scale. Numbered
circles denote individual cell regions. (C)
Quantitative record of calcium flux in the
four individually marked cells. Flux curve
line colours and numbering match the
region boundary colours and numbering
in (B).
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the non-responsive (3 and 4) cells in this image field (Fig. 2C). To
verify that non-responsiveness in this assay was not due to inade-
quate uptake of the fluo-4-AM indicator or artifactual depletion of
intracellular calcium stores, we stimulated the cells with the calcium
ionophore ionomycin at the conclusion of the primary response
observation period. Ionomycin-induced intracellular flux was uni-
formly detected regardless of the initial calcium response level of
the cells (Fig. S2), verifying the specificity of the calcium stimulation
outcome.
We initially suspected that expression of the CASR could be the
determinant factor that distinguished calcium-responsive from non-
responsive cells. To test this idea, we performed calcium flux mea-
surements in a series of primary parathyroid adenoma specimens
and then probed the cells for CASR protein expression via immunoflu-
orescence in situ on the microraft grids. Anti-CASR immunofluores-
cence intensity was not predictive of calcium responsiveness. The
mean  S.D. CASR intensity value (pixel intensity per cell) for
responsive cells was 2.809  0.474 [n = 285; 95% confidence inter-
val (CI): 2.221–3.397], while the intensity value for non-responsive
cells was 2.574  1.220 (n = 180; 95% CI: 1.968–3.181). The
P-value for difference between the mean CASR intensity values in
responsive and non-responsive cells was 0.625. The relatively wide
CIs for CASR expression among responsive and non-responsive cells
suggested that CASR-positive cells could be found in both groups.
Aggregate data from four different adenoma specimens support this
notion. While CASR-expressing cells were enriched among respon-
ders (790 CASR-positive cells/1283 responsive cells), 38.4% of cal-
cium-responsive cells did not express detectable CASR protein (493
CASR-negative cells/1283 responsive cells), and conversely, 32.3%
of non-responding cells did express CASR (883 CASR-positive cells/
2732 non-responsive cells) (Table S2). The mean  S.D. proportion
of cells in each category (CASR-positive/responsive, CASR-positive/
non-responsive, CASR-negative/responsive, CASR-negative/non-
responsive) for the four specimens demonstrates that CASR-nega-
tive/responsive and CASR-positive/non-responsive cells are
consistently observed among the four samples tested (Fig. 3). These
data suggest that CASR expression is not the sole determinant of
calcium responsiveness in parathyroid adenoma cells.
We observed that the kinetic profiles of calcium responsiveness
among parathyroid tumour cells could be classified into five tempo-
rally distinct patterns (Fig. 4). Responsive cells displayed either a
rapid, transient flux peak (Fig. 4A), a slowly rising flux increase
(Fig. 4B), a sustained maximal response (Fig. 4C) or multiple flux
peaks (Fig. 4D). Non-responsive cells showed minimal flux after cal-
cium stimulus and represent the fifth profile pattern (Fig. 4E). Distri-
bution of adenoma cells among these categories was heterogeneous
(Table S3) and highly variable at or just above physiological calcium
concentration levels (1.25 and 2 mM) but progressively consolidated
into either the non-responsive or maximally responsive categories at
higher calcium concentrations (>3 mM) (Fig. 5, Table S4). Non-
responsive cells predominated at sub-physiological (<1.25 mM) cal-
cium levels.
Because the proportion of cells manifesting a maximal response
profile appeared to increase in a concentration dependent manner
(Fig. 5, Fig. S3 and Table S4), we reasoned that quantitative analysis
of this functional biochemical relationship could reveal compromised
calcium sensitivity in parathyroid adenomas. To examine the dose–
response relationship between the proportion of maximally responsive
cells in a given tumour and extracellular calcium concentration, we
performed a series of flux measurements in 11 consecutive primary
parathyroid adenoma specimens. The cells were challenged with a zero
calcium media control or with extracellular calcium to a final concen-
tration of 0.5, 0.75, 1, 1.25, 2, 3, 5 or 10 mM, and the proportion of
maximally responsive cells was recorded. The normalized data were
plotted as a function of log calcium concentration and fitted into a
standard dose–response curve using a variable slope four-parameter
logistic model. As shown in Figure 6, the adenomas tested appeared
to segregate into two distinct groups with respect to calcium sensitiv-
ity. The mean calcium EC50 of the first group was 2.40 mM (95% CI:
2.37–2.41 mM), which is closely aligned with the published sensitivity
conferred by wild-type CASR [20]. The calcium EC50 for the second
group was 3.61 mM (95% CI: 3.45–3.95 mM), which is indicative of
attenuated calcium responsiveness. The difference between the mean
calcium EC50 values was highly significant, with a P < 0.0001.
Discussion
Intratumoural heterogeneity is widely recognized as a critical factor in
nearly all human solid tumours [28–30], but the lack of streamlined
tools for examining live-cell functional diversity in real time from
human tumour tissue remains a significant translational challenge.
Current methodologies based on static classification of fixed human
tissue or on murine modelling using genetically engineered induced
CASR + CASR –
Max. responders
Non-responders
61.6 38.4
32.3 67.7
Fig. 3 Relationship of calcium responsiveness and CASR expression.
Distribution of cells in each category is expressed as mean percent-
age  S.D. from four independent patient samples. Immunofluores-
cence images of representative CASR+ and CASR cells below each
respective column. Green = anti-CASR; blue = DAPI.
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tumours or patient-derived xenograft approaches are clearly informa-
tive but limited by a number of important considerations. Genomic
profiling coupled with histopathological analysis is a powerful
approach for molecular classification, but it does not directly measure
dynamic function. Murine systems relying on candidate gene manipu-
lation may not reflect the multifactorial origin, heterogeneous cellular
composition, and complex physiological behaviour of native tumours.
Patient-derived xenograft models provide a better context for evaluat-
ing tumour heterogeneity, but experiments using these systems are
expensive, labour-intensive, and time-consuming. Here, we describe
a simple, ex vivo approach for dynamic functional interrogation of live
parathyroid adenoma cells collected directly from surgically resected
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Fig. 4 Kinetic response patterns of parathyroid cells after calcium stimulus. Mean fluorescence intensity (MFI) is shown on the y-axis; observation
time (10 min. total) is shown on the x-axis. (A) Rapid/transient response. (B) Slowly rising response. (C) Maximal response. (D) Multiple peak
response. (E) Non-responsive.
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Fig. 5 Proportional distribution of cells in
five kinetic response categories at differ-
ent calcium concentrations. Bars indicate
mean proportion  S.D. from 11 ade-
noma samples.
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human tumour tissue. By evaluating the functional behaviour of these
cells at single-cell resolution, we can quantitate the effects of intratu-
moural heterogeneity on calcium responsiveness, the key physiologi-
cal activity underlying the clinical presentation of PHPT. Because our
platform utilizes direct observation of individual cellular behaviours,
the system can easily be adapted for examining specimens where cell
numbers are limiting. Ex vivo provocative testing of human tumour
tissue in this manner could potentially provide improved diagnostic
precision and functional insight into the dynamic biochemical beha-
viour of multiple types of human solid tumours.
Our approach does carry certain limitations that could affect inter-
pretation of these experiments. It is possible that selective cellular
recovery or survival could create biased representation in the cellular
populations seeded into the grids. Although we cannot rule out the
potential for biased recovery, collagenase digestion is an established
procedure for cellular harvest from intact tissue; in addition, we have
not observed consistent digestion-resistant structures, and the ultra-
structural morphology of cells isolated in this manner matches their
appearance in intact tissue [21]. We feel that selective cell death is
unlikely to be a significant factor, as the overall viability of parathyroid
cells in our system is consistently >90% (Fig. 1D). We recognize that
positional information and tumour microenvironment context are not
preserved in dispersed cell systems and that appropriate subcellular
trafficking and activity of the CASR protein might be at least partially
dependent upon intact tissue structure. We have in fact observed
intratumoural heterogeneity in CASR protein localization (Fig. S4),
although the overall proportion of CASR-positive and CASR-negative
cells in the microraft arrays is consistent with what we observe in tis-
sue sections from the parental tumours. We are currently developing
a modified device to allow visualization of calcium flux behaviour in
intact parathyroid adenoma slice cultures.
Our observation that CASR protein abundance alone does not dic-
tate calcium responsiveness supports the concept of mechanistic
heterogeneity in the failure of calcium sensing in parathyroid adeno-
mas. Alterations in a number of proteins that operate in the CASR sig-
nal transduction pathway have been associated with disruptions of
calcium sensing. For example, in previous work we have shown that
increased expression of the G-protein regulatory protein RGS5 can
attenuate calcium sensing in human cells and in a transgenic mouse
model [15]. Conversely, germ-line inactivating mutations in the gua-
nine nucleotide binding protein G-alpha11 or in the protein-trafficking
complex protein AP2S1 cause the calcium sensing disorders of famil-
ial hypocalciuric hypercalcemia Types II and III, respectively [19, 20].
Somatic mutations in these genes have not been reported in PHPT
[12–14], but this could be because the relevant subset of functionally
non-responsive cells was underrepresented in the bulk tumour sam-
ples used in the genomic studies published to date. Future studies uti-
lizing selective microraft capture of functionally characterized
parathyroid adenoma cells are likely to reveal molecular genetic fea-
tures specifically associated with diminished calcium sensing even in
the presence of intact CASR protein expression.
The variable kinetic patterns of adenoma cell responsiveness to
extracellular calcium challenge reveal yet another level of intratu-
moural heterogeneity in these complex tumours. The greatest degree
of diversity in the proportional distribution among kinetic response
profiles occurs at or near physiological calcium concentrations, sug-
gesting that the presence of the full spectrum of signalling patterns
represents an equilibrium state in parathyroid gland tissue. Consoli-
dation into a binary distribution of maximally responsive or non-
responsive cells at higher calcium concentrations suggests that the
calcium signalling response of parathyroid cells is saturable in a man-
ner similar to that observed in cultured cells stably expressing wild-
type CASR protein [31], where higher calcium concentrations induce
a sustained elevation of intracellular calcium release [32]. Hetero-
geneity in the calcium response profiles of parathyroid cells from a
given sample could indicate the co-existence of subpopulations with
different calcium setpoints within each tumour. The respective func-
tions and interactions of these differing cellular subsets remain
unknown but are the subject of active investigation.
Although the initial sample group in the current study (Table S5)
is too small to support any conclusive inferences on possible associa-
tions between biochemical behaviour and clinical parameters, the
observed variation in tumour cell calcium responsiveness evokes a
number of intriguing hypotheses for further investigation. The appar-
ent segregation of an unselected series of PHPT adenomas into sepa-
rable groups on the basis of calcium EC50 values suggests the
existence of biochemically distinct subclasses of PHPT, possibly
reflecting differing etiological mechanisms. The fact that one group
displays calcium responsiveness similar to the reported value for
wild-type CASR implies that a subset of parathyroid tumours may be
intrinsically capable of appropriate calcium sensing to some degree.
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Fig. 6 Dose–response curves depicting proportion of maximally respon-
sive cells as a function of log calcium concentration. Data points repre-
sent mean  S.D. from three independent fields of >200 cells/field for
each calcium concentration from each patient sample. Traces of 11 ade-
noma samples are shown.
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It is possible that these normal-sensing tumours arise in a manner
more akin to secondary HPT, where hyperplasia is driven by meta-
bolic conditions or other events that do not directly compromise cal-
cium sensing. In PHPT adenomas with normal calcium sensitivity, the
presence of an initiating genetic lesion could have driven clonal
expansion of a parathyroid tumour without necessarily impinging
upon intrinsic calcium responsiveness. In contrast, polyclonal expan-
sion of a parathyroid tumour could occur as a consequence of failed
calcium sensing, with tumour growth directly linked to abrogated
CASR activity as has been demonstrated in other tumour types [33,
34]. The extent of association between clonal status and calcium
EC50 is currently being tested (Fig. S5). Ongoing efforts to establish
definitive linkage between parathyroid adenoma cell functional
properties and clinical parameters, disease course and outcome will
require larger patient cohorts drawn from a systematically assembled
parathyroid tumour registry database.
In summary, functional characterization of parathyroid intratu-
moural heterogeneity with respect to calcium sensing reveals a previ-
ously unappreciated degree of complexity in the etiopathogenesis and
clinical diversity of PHPT. The development of a live-cell observation
platform that can align dynamic interrogation of functional behaviour
with subsequent immunofluorescence image analysis and future
downstream genomic profiling at single cell resolution provides a
valuable new tool for dissecting the molecular basis of compromised
calcium sensing in PHPT. The concept of live-cell functional interro-
gation as a means of tumour classification could have important
implications for the development of improved prognostic and predic-
tive clinical management guidelines.
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